Wei‐Bang Guo

1.1k total citations
29 papers, 662 citations indexed

About

Wei‐Bang Guo is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Wei‐Bang Guo has authored 29 papers receiving a total of 662 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 16 papers in Pulmonary and Respiratory Medicine and 12 papers in Molecular Biology. Recurrent topics in Wei‐Bang Guo's work include Lung Cancer Treatments and Mutations (15 papers), Cancer Genomics and Diagnostics (11 papers) and Lung Cancer Research Studies (10 papers). Wei‐Bang Guo is often cited by papers focused on Lung Cancer Treatments and Mutations (15 papers), Cancer Genomics and Diagnostics (11 papers) and Lung Cancer Research Studies (10 papers). Wei‐Bang Guo collaborates with scholars based in China, India and United States. Wei‐Bang Guo's co-authors include Yi‐Long Wu, Jin‐Ji Yang, Hai‐Yan Tu, Hong‐Hong Yan, Qing Zhou, Yang-Si Li, Ben‐Yuan Jiang, Xu‐Chao Zhang, Jian Su and Wen‐Zhao Zhong and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Journal of the American Ceramic Society.

In The Last Decade

Wei‐Bang Guo

29 papers receiving 654 citations

Peers

Countries citing papers authored by Wei‐Bang Guo

Since Specialization

Citations

This map shows the geographic impact of Wei‐Bang Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei‐Bang Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei‐Bang Guo more than expected).

Fields of papers citing papers by Wei‐Bang Guo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei‐Bang Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei‐Bang Guo. The network helps show where Wei‐Bang Guo may publish in the future.

Co-authorship network of co-authors of Wei‐Bang Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Wei‐Bang Guo. A scholar is included among the top collaborators of Wei‐Bang Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei‐Bang Guo. Wei‐Bang Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Plasma EBV quantification is associated with the efficacy of immune checkpoint blockade and disease monitoring in patients with primary pulmonary lymphoepithelioma‐like carcinoma 2024 ·Clinical & Translational Immunology ·(unknown), (unknown), Jie Jiang, Wenbin Zhou, Lingling Gao, (unknown), Wenqing Yan, Yu Chen, (unknown), (unknown), Zhiyi Lv, Zhi Xie, Ying Huang, Wei‐Bang Guo, (unknown), Jin‐Ji Yang, Xue‐Ning Yang, Yi‐Long Wu, Xu‐Chao Zhang	2
2	Circulating tumor cells dynamics during chemotherapy predict survival and response in advanced non-small-cell lung cancer patients 2023 ·Therapeutic Advances in Medical Oncology ·Zhen Wang, Xu‐Chao Zhang, Weineng Feng, Li Zhang, Xiaoqing Liu, Wei‐Bang Guo, Yanming Deng, (unknown), Jin‐Ji Yang, Qing Zhou, Bin-Chao Wang, Hua‐Jun Chen, Hai‐Yan Tu, Hong‐Hong Yan, Yi‐Long Wu	5
3	High SHP2 expression determines the efficacy of PD‐1/PD‐L1 inhibitors in advanced KRAS mutant non‐small cell lung cancer 2021 ·Thoracic Cancer ·(unknown), Yu Chen, Zhi Xie, Jie Jiang, (unknown), Wei‐Bang Guo, Wenqing Yan, Zhiyi Lv, (unknown), (unknown), Fangping Xu, Jin‐Ji Yang, Xue‐Ning Yang, Qing Zhou, (unknown), Zhou Zhang, Shaokun Chuai, Henghui Zhang, Yi‐Long Wu, Xu‐Chao Zhang	9
4	TMB and TCR Are Correlated Indicators Predictive of the Efficacy of Neoadjuvant Chemotherapy in Breast Cancer 2021 ·Frontiers in Oncology ·(unknown), Jia Huang, Xiang Ao, Wei‐Bang Guo, Yu Chen, (unknown), Zhiyi Lv, Xiaojun Tan, (unknown), Ming Jiang, Haoming Xia, (unknown), Weiling Guo, Zhiqing Ye, Lei Jiao, Jie Ma, Changxi Wang, Hongsheng Li, Xu‐Chao Zhang, (unknown), (unknown)	7
5	Establishment and application of a method of next generation sequencing of 285 genes in lung cancer based on Ion-Proton platform 2020 ·Translational Cancer Research ·Yu Chen, Xuchao Zhang, Wenqing Yan, Wei‐Bang Guo, Zhi Xie, (unknown), Zhiyi Lv, Zhihong Chen, Jian Su	1
6	Relationship of circulating tumor cells and Epstein–Barr virus DNA to progression‐free survival and overall survival in metastatic nasopharyngeal carcinoma patients 2019 ·International Journal of Cancer ·Rui You, You‐Ping Liu, Mei Lin, Pei‐Yu Huang, Lin‐Quan Tang, Yi‐Nuan Zhang, Yi Pan, (unknown), Wei‐Bang Guo, Xiong Zou, (unknown), Ting Kang, Lizhi Liu, Aihua Lin, Ming‐Huang Hong, Hai‐Qiang Mai, Mu‐Sheng Zeng, Ming‐Yuan Chen	34
7	Low frequency of mutation of epidermal growth factor receptor (EGFR) and arrangement of anaplastic lymphoma kinase (ALK) in primary pulmonary lymphoepithelioma‐like carcinoma 2019 ·Thoracic Cancer ·Kai Yin, (unknown), (unknown), Yu Chen, Zhi Xie, Zhiyi Lv, Wei‐Bang Guo, (unknown), Xue‐Ning Yang, Wenqing Yan, Yi‐Long Wu, Xu‐Chao Zhang	12
8	Clinical Utility of Cerebrospinal Fluid Cell-Free DNA as Liquid Biopsy for Leptomeningeal Metastases in ALK-Rearranged NSCLC 2019 ·Journal of Thoracic Oncology ·Mei-Mei Zheng, Yang-Si Li, Ben‐Yuan Jiang, Hai‐Yan Tu, Wen‐Fang Tang, Jin‐Ji Yang, Xuchao Zhang, Junyi Ye, Hong‐Hong Yan, Jian Su, Qing Zhou, Wen‐Zhao Zhong, Xue‐Ning Yang, Wei‐Bang Guo, Shannon Chuai, Zhou Zhang, Hua‐Jun Chen, Zhen Wang, Chao Liu, Yi‐Long Wu	75
9	Intratumoral heterogeneity of EGFR-activating mutations in advanced NSCLC patients at the single-cell level 2019 ·BMC Cancer ·Longhua Guo, Zhihong Chen, Chong‐Rui Xu, Xuchao Zhang, Hong‐Hong Yan, Jian Su, Jin‐Ji Yang, Zhi Xie, Wei‐Bang Guo, Feng Li, Yi‐Long Wu, Qing Zhou	16
10	Crizotinib in advanced non-small-cell lung cancer with concomitant ALK rearrangement and c-Met overexpression 2018 ·BMC Cancer ·Ruilian Chen, Jun Zhao, Xu‐Chao Zhang, (unknown), Hua‐Jun Chen, Xue Yang, Jian Su, Zhi Xie, Qing Zhou, Hai‐Yan Tu, Wen‐Zhao Zhong, Hong‐Hong Yan, Wei‐Bang Guo, Yi‐Long Wu, Jin‐Ji Yang	24
11	[Detection of UGT1A128 Polymorphism Using Fragment Analysis]. 2017 ·SHILAP Revista de lepidopterología* ·Ying Huang, Jian Su, (unknown), (unknown), Zhi Xie, (unknown), Wei‐Bang Guo, Zhiyi Lv, (unknown), Xuchao Zhang	1
12	Establishment of a Novel Method for Screening Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Resistance Mutations in Lung Cancer 2017 ·Chinese Medical Journal ·(unknown), Xu‐Chao Zhang, Zhen Wang, Jin‐Ji Yang, Wei‐Bang Guo, Zhihong Chen, Yi‐Long Wu	1
13	Stromal PD-L1–Positive Regulatory T cells and PD-1–Positive CD8-Positive T cells Define the Response of Different Subsets of Non–Small Cell Lung Cancer to PD-1/PD-L1 Blockade Immunotherapy 2017 ·Journal of Thoracic Oncology ·Si-Pei Wu, Ri-Qiang Liao, Hai‐Yan Tu, Wenjun Wang, Zhong‐Yi Dong, Shu‐Mei Huang, Wei‐Bang Guo, Lan-ying Gou, Huiwen Sun, Qi Zhang, Zhi Xie, Li‐Xu Yan, Jian Su, Jin‐Ji Yang, Wen‐Zhao Zhong, Xu‐Chao Zhang, Yi‐Long Wu	120
14	Leptomeningeal Metastases in Patients with NSCLC with EGFR Mutations 2016 ·Journal of Thoracic Oncology ·Yang-Si Li, Ben‐Yuan Jiang, Jin‐Ji Yang, Hai‐Yan Tu, Qing Zhou, Wei‐Bang Guo, Hong‐Hong Yan, Yi‐Long Wu	211
15	Integrative Analyses of Lung Squamous Cell Carcinoma in Ten Chinese Patients with Transcriptome Sequencing 2015 ·Journal of genetics and genomics ·Lulu Yang, Xu‐Chao Zhang, Shaokun Chuai, Zhihong Chen, (unknown), Wei‐Bang Guo, Shiliang Chen, Yuanyuan Lei, Longhua Guo, Lan-ying Gou, Huiwen Sun, Qi Zhang, Jin‐Ji Yang, Hai‐Yan Tu, Jian Su, Yi‐Long Wu	2
16	Anaplastic Lymphoma Kinase Variants and the Percentage of ALK-Positive Tumor Cells and the Efficacy of Crizotinib in Advanced NSCLC 2015 ·Clinical Lung Cancer ·Yuanyuan Lei, Jin‐Ji Yang, Xu‐Chao Zhang, Wen‐Zhao Zhong, Qing Zhou, Hai‐Yan Tu, (unknown), Wei‐Bang Guo, Lulu Yang, Hong‐Hong Yan, Hua‐Jun Chen, Zhi Xie, Jian Su, (unknown), Yi‐Long Wu	41
17	ROS1 rearrangement coexists with EGFR mutation in non-small-cell lung cancer. 2015 ·Journal of Clinical Oncology ·Ruilian Chen, Jin‐Ji Yang, Xu‐Chao Zhang, (unknown), Huajun Chen, Qing Zhou, Jian Su, Wei‐Bang Guo, Jianguang Chen, Hai‐Yan Tu, Yue‐Li Sun, Yi‐Long Wu	1
18	Single Nucleotide Polymorphisms in VTI1A Gene Contribute to the Susceptibility of Chinese Population to Non-Small Cell Lung cancer 2015 ·The International Journal of Biological Markers ·Wenmei Su, Zhihong Chen, Xuchao Zhang, Jian Su, Zhi Xie, Hong‐Hong Yan, Jin‐Ji Yang, Hua‐Jun Chen, Qing Zhou, Wen‐Zhao Zhong, Wei‐Bang Guo, Shiliang Chen, Yi‐Long Wu	7
19	Detecting the spectrum of multiplex gene mutations in non-small cell lung cancer by Snapshot assay 2014 ·Chinese Journal of Cancer ·Jian Su, Xu‐Chao Zhang, Shejuan An, Wen‐Zhao Zhong, Ying Huang, Shiliang Chen, Hong‐Hong Yan, Zhi Hong Chen, Wei‐Bang Guo, (unknown), Yi‐Long Wu	13
20	Combinations of laminin 5 with PTEN, p-EGFR and p-Akt define a group of distinct molecular subsets indicative of poor prognosis in patients with non-small cell lung cancer 2012 ·Experimental and Therapeutic Medicine ·Shejuan An, Qiu‐Xiong Lin, Zhihong Chen, Jian Su, Hua Cheng, Zhi Xie, Xu‐Chao Zhang, Haiyu Zhou, Ying Huang, Shiliang Chen, Wei‐Bang Guo, Yi‐Long Wu	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact